Pfizer's Obesity Drug Deal, Oracle's TikTok Algorithm Role, and Google's DOJ Lawsuit

Pfizer Acquires Obesity Startup Metsera

• 💊 Pfizer is acquiring the obesity startup Metsera Inc. for an enterprise value of approximately $4.9 billion.
• 🎯 This strategic move aims to bolster Pfizer's pipeline, particularly after challenges with its existing weight-loss medication.
• 💰 The deal includes an upfront payment of $47.50 per share in cash, with potential additional payments of up to $22.50 per share tied to specific regulatory milestones.
• 📈 The acquisition represents a 43% premium to Metsera's closing share price on Friday.

Oracle's Role in TikTok's US Version

• 📱 Oracle is set to play a crucial role in the US version of TikTok's algorithm, providing security and retraining services.
• 🤝 This arrangement is part of a potential deal to sell TikTok to a consortium of American investors, ensuring US control over its recommendation software.
• ⚙️ Oracle will partner with the US government to manage algorithm retraining, application development, and source code review to prevent improper manipulation or surveillance.
• ☁️ US user data will be stored in a secure Oracle-managed cloud, with safeguards against foreign adversaries.
• 🚀 Oracle shares have seen a significant rise this year, and the company also announced new joint chief executive officers.

Alphabet (Google) Faces DOJ Lawsuit

• ⚖️ The Justice Department is pursuing legal action to force a breakup of Alphabet's Google, focusing on its advertising exchange, AdX.
• 📈 The DOJ alleges that Google illegally monopolized the online display advertising market and seeks the divestiture of AdX to restore competition.
• 🚫 Google argues that a full divestiture is unnecessary and has proposed making its ad tech tools compatible with rivals', stating that a breakup would harm publishers and advertisers.
• 🏛️ The case is proceeding in a Virginia federal court, with potential implications for Google's advertising technology business.